Prestige Consumer Healthcare Inc. · NYSE:PBH
Prestige Consumer Healthcare — Prestige Brands Holdings — Investor Presentation (December 2014)
36 slides from Prestige Consumer Healthcare's investor presentation, December 2014
Slide 1: Investor Presentation December 2014
Investor Presentation December 2014
Slide 2: Safe Harbor Disclosure
Safe Harbor Disclosure This presentation contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company’s product introductions, investments in brand building, debt reduction, integration of the Insight a
Slide 3: 3
3 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 3
Slide 4: Key Drivers of Long-Term Shareholder Value
Key Drivers of Long-Term Shareholder Value Portfolio of recognizable brands in attractive consumer health industry 1 Develop a Established expertise in brand building and product innovation Portfolio of Leading Demonstrated ability to gain market share long-term Brands Target revenue contrib
Slide 5: Strategy Has Delivered Consistently Strong Financial Performance
Strategy Has Delivered Consistently Strong Financial Performance Net Sales Adjusted EBITDA $800 $300 $602 $204 $441 $135 $293 $88 (1) (2) (2) (2) (3) FY'10A FY'12A FY'14A FY'15PF FY'10A FY'12A FY'14A FY'15PF Adjusted EPS Adjusted Free Cash Flow $1.90 to $2.00 $175 $1.53 $129 $0.99 $0.67 $59 $67 (4)
Slide 6: Develop a Portfolio of Leading Brands
1 Develop a Portfolio of Leading Brands 6 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 6
Slide 7: Recognizable Brands with Leading Market Positions
1 Recognizable Brands with Leading Market Positions #1 and #2 Market Position Brands 7 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 7 Source: Based on IRI multi-outlet retail sales
Slide 8: Demonstrated Ability to Build Brands
1 Demonstrated Ability to Build Brands Product Innovation A&P Investment Consumption Change 13.3% 10.9% Category 5.4% 6.0% 2.0% 0.7% 3 Yr* 52 Weeks** 12 Weeks** Source: IRI multi-outlet retail dollar sales growth for relevant period. 8 * Represents change over 3I most N Vrecently E S Treported O R F
Slide 9: Demonstrated Ability to Build Brands
1 Demonstrated Ability to Build Brands Product Innovation A&P Investment Travel Site Online Social Media Banners Videos Presence Consumption Change 21.7% Category 14.8% 12.5% 10.5% 10.8% 8.3% 3 Yr* 52 Weeks** 12 Weeks** Source: IRI multi-outlet retail dollar sales growth for relevant period. 9 * Rep
Slide 10: Demonstrated Ability to Build Brands
1 Demonstrated Ability to Build Brands Product Innovation A&P Investment Multi-year agreement with Dale Earnhardt, Jr. for the NASCAR XFINITY Series Consumption Change 7.5% Category 2.4% 1.2% 1.3% 0.9% 0.7% 3 Yr* 52 Weeks** 12 Weeks** Source: IRI multi-outlet retail dollar sales growth for relevant
Slide 11: Momentum in Consumption Has Resulted in Share Gains
1 Momentum in Consumption Has Resulted in Share Gains Core OTC Consumption Growth Core OTC Market Share 11.8% 11.6% 11.9% 11.1% 11.4% 8.7% 8.3% 10.6% 7.1% 10.0% 10.0% 10.2% 9.8% 5.2% 3.9% 0.8% 1.0% (1.8%) (1.8%) (4.9%) FY'12 FY'13 FY'14 Q1 Q2 FY'12 FY'13 FY'14 Q1 Q2 FY’15 FY’15 Excluding PediaCare C
Slide 12: Recent Trends and Underlying Growth
1 Recent Trends and Underlying Growth FY14 Transitional Year Consumption Growth* 7.1% 5.2% 3.9% 0.8% (1.8%) Returning Products Reduced Cough & Cold Incident Levels Retailer Inventory Adjustments Organic Sales Growth* 5.2% 3.9% 0.0% (2.4%) (3.5%) FY'12 FY'13 FY'14 Q1 Q2 FY’15 12 I N V E S T O(2
Slide 13: International Markets Gaining Importance
1 International Markets Gaining Importance 2011 2014 International International 10% ~15% U.S. U.S. 90% ~85% Distributor model Local operations in Australia and New Predominantly established markets Zealand Beachhead for attractive region Attractive growth profile International Business Ha
Slide 14: Disciplined Portfolio Management Strategy
1 Disciplined Portfolio Management Strategy Invest for Growth Manage for Cash Flow Generation Core OTC International Other OTC Household 11% 63% 12% Contribution to 14% Portfolio: 16 4 50 3 # of Brands: ~25% of Total Brands ~75% of Total Brands Investment: High High Maintain Maintain Targeted Mix Ov
Slide 15: Capitalize on Efficient and Effective Operating Model
2 Capitalize on Efficient and Effective Operating Model 15 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 1 5
Slide 16: Margin Expansion and Efficiency Gains Allows for Increased A&P Investment
2 Margin Expansion and Efficiency Gains Allows for Increased A&P Investment Adjusted Gross Margin(7) Adjusted G&A % Net Sales(7) 56.6% 56.7% 10.2% 8.5% 52.9% 7.9% 52.0% 7.2% FY'11A FY'12A FY'13A FY'14A FY'11A FY'12A FY'13A FY'14A A&P % Net Sales Adjusted EBITDA Margin(8) 14.5% 14.9% 12.7% 13.0% 34.9
Slide 17: Prestige Operating Model
2 Prestige Operating Model Leverage Internal and External Resources as One Integrated System Best-in-Class Outsourced Partners Marketing Brand Advertising Management Product Development Logistics Customer IT Service Sales Manufacturing Finance Distribution Product Quality Specialized Skills and Kn
Slide 18: Key Benefits of Our Operating Model
2 Key Benefits of Our Operating Model Ensures Organizational Focus on Brand Building Provides Access to Additional Technical Resources for New Product Development Broad Base of Manufacturer’s Industry Knowledge Efficient, Scalable and Flexible Model State-of-the-Art Manufacturing with Mini
Slide 19: Efficient Organizational Structure Supports Next Phase of Growth
2 Efficient Organizational Structure Supports Next Phase of Growth Employees Revenue Adjusted EBITDA +2.2x +2.7x +3.1x $800 195 87 $293 $300 $88 (1) (2) (3) FY'10 PF FY'15 FY'10 PF FY'15 FY'10 PF FY'15 Efficiencies allow organization to build new competencies Increased investment focused on sale
Slide 20: Deliver Robust and Consistent Free Cash Flow
3 Deliver Robust and Consistent Free Cash Flow 20 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 2 0
Slide 21: Drivers of Free Cash Flow
3 Drivers of Free Cash Flow Superior EBITDA margin profile Outsourced manufacturing with minimal capital outlays Disciplined acquisition strategy with proven integration synergies and structured in a highly tax- efficient manner Low cash tax rate from significant long-term tax attributes Adj
Slide 22: Industry Leading EBITDA Margins
3 Industry Leading EBITDA Margins Adjusted EBITDA Margins ~37% (11) 33.8% 27.6% 27.4% 23.1% 22.8% 22.0% 20.2% 19.9% 16.8% 15.6% 13.7% 11.5% Median: 22.0% 22 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 2 2 Source: Company filings and Capital IQ
Slide 23: Superior Free Cash Flow Conversion
3 Superior Free Cash Flow Conversion Adjusted Yield(12) and FCF Conversion(9) 9% ~175% (13) 8% 152.4% 5% 135.2% 6% 125.9% 4% 117.5% 5% 114.8% 6% 112.5% 5% 111.5% 5% 109.5% 6% 107.9% 7% 96.0% 5% 93.6% 5% 84.3% Median: 5% Median: 112.5% 23 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0
Slide 24: Rapid De-Leveraging Builds Acquisition Capacity
3 Rapid De-Leveraging Builds Acquisition Capacity Leverage Ratio(14) Illustrative Financing Capacity(15) ~5.6x ~$2.1 BN ~5.3x ~4.5x ~$1.3 BN <4.0x ~$0.4 BN Q2 FY'15 FY'15E FY'16E FY'17E FY'15E FY'16E FY'17E High free cash flow conversion is expected to lead to Existing financing arrangements and
Slide 25: Execute Proven and Repeatable M&A Strategy
4 Execute Proven and Repeatable M&A Strategy 25 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 2 5
Slide 26: Recurring Flow of Quality Opportunities in OTC Over Time
4 Recurring Flow of Quality Opportunities in OTC Over Time (Consumer) (European & (OTC JV) ROW Brands) (7 OTC Brands) (17 OTC Brands) (Consumer Brands) ® (Non Core OTC) (5 Brands) (Minors) (LatAm Brands) 2007 2008 2009 2010 2011 2012 2013 2014 26 I N V E S T O R P R E S E N T A T I O N D E C E M B E
Slide 27: M&A Strategy has Delivered Shareholder Value
4 M&A Strategy has Delivered Shareholder Value Pure Play OTC Platform Position of Strength Disciplined M&A as a and Value Aggressive Creator M&A Strategy Attractive Pricing Number Dynamics and Scale of Opportunities 27 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 2 7
Slide 28: Proven Ability to Source from Varied Sellers
4 Proven Ability to Source from Varied Sellers 28 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 2 8
Slide 29: Recent Acquisitions Have Transformed Our Business
4 Recent Acquisitions Have Transformed Our Business 2010 2011 2012 2013 2014 North American Brands Platform Expansion September 2010 December 2010 December 2011 April 2014 Geographic Expansion July 2013 April 2014 Six Acquisitions Completed in Past Five Years Have More Than Tripled Prestige’s OTC Bu
Slide 30: Strengthening Brand Scale in OTC
4 Strengthening Brand Scale in OTC FY2010(16) FY2015(17) Average: $38MM* Average: $113MM* Brand Scale in Top 4 OTC Brands +3.0x 30 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 3 0 * Retail Sales
Slide 31: 31
31 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 3 1
Slide 32: Q2 Performance Highlights
Q2 Performance Highlights Q2 consolidated Total Revenue of $181.3 million, up 8.6% versus the prior year corresponding quarter Adjusted E.P.S. of $0.50(18), up 6.4% versus the prior year corresponding quarter Strong Adjusted Free Cash Flow of $36.5(18) million, up 14.7% versus the prior year c
Slide 33: Key Drivers of Long-Term Shareholder Value
Key Drivers of Long-Term Shareholder Value Portfolio of recognizable brands in attractive consumer health industry 1 Develop a Established expertise in brand building and product innovation Portfolio of Leading Demonstrated ability to gain market share long-term Brands Target revenue contrib
Slide 34: Q&A
Q&A 34 I N V E S T O R P R E S E N T A T I O N D E C E M B E R • 2 0 1 4 3 4
Slide 35: Appendix
Appendix (1) Pro forma Net Sales is projected for FY15 as if Insight and Hydralyte were acquired on April 1, 2014. (2) Adjusted EBITDA is a Non-GAAP financial measure and may be found in our earnings releases for each respective year ended March 31 and is reconciled to GAAP Net Income in Exhibit 99.
Slide 36: Appendix (cont.)
Appendix (cont.) (11) Pro Forma Adjusted EBITDA margin is a Non-GAAP financial measure and is arrived at by taking Pro Forma Adjusted EBITDA of $300 million divided by Pro Forma Net Sales of $800 million. Pro Forma Adjusted EBITDA is a projected Non-GAAP financial measure and is arrived at by taking
Prestige Brands Holdings — Investor Presentation (December 2014) on 6ix